Strong Or Moderate Cyp3a Inducers + Omaveloxolone Interaction
Majorinteraction on record
Description
Concomitant use results in clinically significant decreased exposure of omaveloxolone, which may reduce the effectiveness of SKYCLARYS. Avoid concomitant use.
Mechanism
CYP3A4 induction decreases omaveloxolone exposure
Source: NLP:omaveloxolone